Effect of polyanion-resistance on HIV-1 infection

Virology
Michael D BobardtPhilippe A Gallay

Abstract

Polyanions are potent HIV-1 entry inhibitors. Nevertheless, resistant viruses may emerge under polyanion inhibitory pressure. Specifically, a polyanion-resistant virus replicates in T cells even in the presence of high concentrations of polyanions. We found that although the polyanion-resistant virus grows in suspension CD4+ T cells efficiently, it infects nonlymphocytic adherent CD4+ cells poorly. Given that a main distinction between suspension and adherent cells is the absence or presence of cell-surface heparan sulfate proteoglycan (HSPG), we investigated if the failure of the polyanion-resistant virus to infect adherent CD4+ cells arises from its inability to bind HSPG. We found that the emergence of mutations in gp120 associated with polyanion resistance resulted in a decreased capacity of HIV-1 to bind HSPG. We also found that the polycation polybrene rescued the capacity of the polyanion-resistant virus to bind HSPG and to infect adherent CD4+ cells. The identification of this virus, unable to bind HSPG, provides a convenient probe to measure the impact of HIV-1-HSPG interactions in vivo. Altogether, these findings suggest that polyanion-resistance narrows the range of potential target cells for HIV-1 in the host. This ...Continue Reading

References

Jan 16, 1992·Biochimica Et Biophysica Acta·E MbembaL Gattegno
Feb 1, 1993·AIDS Research and Human Retroviruses·M PatelM A Norcross
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·W K WangT H Lee
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·W K WangT H Lee
Jun 29, 2000·Annual Review of Biochemistry·M BernfieldM Zako
May 7, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ghiabe H GuibingaTheodore Friedmann
Jan 18, 2003·Immunity·Michael D BobardtPhilippe A Gallay

❮ Previous
Next ❯

Citations

Jul 15, 2006·PLoS Pathogens·Christopher B BuckJohn T Schiller
May 5, 2009·Medical Hypotheses·Shubhadeep Banerjee, Sujoy K Guha
Oct 26, 2005·Bioorganic & Medicinal Chemistry Letters·Tibor HianikMarián Antalík
Jul 16, 2005·Annals of Medicine·Sigvard Olofsson, Tomas Bergström
Sep 5, 2006·Antiviral Research·Andrei N VzorovRichard W Compans
May 27, 2014·Journal of Virological Methods·Birco SchwalbeMichael Schreiber
Sep 20, 2005·Virology·Mercedes Armand-UgónJosé A Esté
Nov 5, 2016·Journal of the American Society of Nephrology : JASN·Jinliang LiPatricio E Ray
Aug 19, 2020·Biotechnology Progress·Emily Harris, Jacob J Elmer
Sep 15, 2005·The Journal of Biological Chemistry·Aymeric de ParsevalPhilippe A Gallay
Aug 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nicholas J MantisEdward N Janoff
Jan 28, 2021·Microorganisms·Jean-François BruxelleRalph Pantophlet
Jan 23, 2021·Biotechnology and Bioengineering·Emily HarrisJacob Elmer
Apr 23, 2021·Advanced Healthcare Materials·Fang-Yi SuGabriel A Kwong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.